Generic drugs may gain from stronger Democrats: WSJ
(R


Reuters - The newly empowered Democrats' vow to
cut healthcare costs might spell bad news for the brand-name
pharmaceutical industry, but could provide new momentum for
generic drug rivals, the Wall Street Journal reported on its
Web site on Tuesday.